FDA clears depression device; Hospira rolls out Plum 360;

@FierceMedDev: FDA scolds Cepheid for manufacturing issues in Sweden. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: Updated $ABT's interest in $STJ w/ info from old article on their prior partnership. Neat to add context from 2012. Article | Follow @VarunSaxena2

@EmilyWFierce: ICYMI yesterday: J&J and PCH launch hardware startup accelerator. Story | Follow @EmilyWFierce

> The Chicago, IL-based Propel Center of the iBio Institute has awarded grants to 8 Illinois med tech companies to attend industry conference AdvaMed in San Diego, CA from Oct. 5-7. More

> The FDA has cleared the MagVita TMS Therapy System from MagVenture to treat major depressive disorder in adult patients who don't respond to anti-depressant medication. More

> Symmetry Surgical ($SSRG) has acquired assets from Vesocclude Medical including its product portfolio of titanium ligation clips and appliers for $4 million. More

> Hospira ($HSP) has installed its first Plum 360 infusion system at Shannon Medical Center in San Angelo, Texas. More

Biotech News

@FierceBiotech: UPDATED: Amgen gets a big win with FDA OK for PCSK9 cholesterol drug. Article | Follow @FierceBiotech

@JohnCFierce: Eli Lilly's marginal cancer drug becomes Exhibit A in pricing dilemma. Report | Follow @JohnCFierce

> Stem cell researcher cleared of misconduct after U-turn. Story

> Novo Nordisk buys diabetes startups founded by Lilly R&D veteran. Report

> The FDA offers a controversial solution to the biosimilars name game. Article

Pharma News

@FiercePharma: Patterson shares fall on missed sales and earnings targets. FierceAnimalHealth article | Follow @FiercePharma

@EricPFierce: ICYMI: North Carolina wins Novo prize--$1.2B plant, 700 jobs as Novo builds first US, API plant. Article | Follow @EricPFierce

@CarlyHFierce: Can Sprout's Addyi shrug off serious side effects? These blockbusters did. FiercePharmaMarketing story | Follow @CarlyHFierce

> Celgene nails down $7.2B takeover of Receptos. Item

> J&J brings 500 jobs to Florida with new shared services HQ. More

> Mylan shareholders favor Perrigo takeover. Story

> Sweden's Meda weighs $1B sale of its U.S. business. Article

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.